A new strategy to cure disease in a single day, and forever: epigenetic silencing
By Manuel Ansede,
El País
| 03. 01. 2024
A team of Italian researchers has reached a major scientific milestone, heralding a revolution in the field of medicine. The scientists have succeeded in silencing a gene associated with high cholesterol levels, without the need to modify DNA. In the experiment, which was conducted on mice, the effects of the gene silencing persisted for the entire year that the experiment lasted — a period equivalent to half an average human life. These results suggest that it may be possible to solve chronic health problems, permanently, and in a single day of treatment. The study was published this Wednesday in the journal Nature, a leading reference in the world of science.
DNA is like a book, with some 3 billion chemical letters, that provides instructions for the functioning of every cell. This immense text is divided into pages — the genes — which contain specific recipes for making the proteins necessary for life: the collagen in cartilage, the hemoglobin in blood, the antibodies that fight pathogens. One of these genes, PCSK9, contains guidelines for producing a protein associated with...
Related Articles
By Hannah Devlin, The Guardian | 05.14.2024
Photo by Kind and Curious from Unsplash
When Great Ormond Street hospital (Gosh) published the results of its gene therapy trial for “bubble baby” syndrome it was hailed as a medical breakthrough. The treatment had a more than 95% success...
By Victoria Bisset and Adela Suliman, The Washington Post | 05.09.2024
Photo by CDC from Unsplash
A baby girl born with profound genetic deafness can now hear unaided after receiving a “groundbreaking” gene therapy trial, Britain’s National Health Service said Thursday.
Opal Sandy, an 18-month-old from Oxfordshire, England, is the first...
By Carrie Arnold, Nature Biotechnology | 04.17.2024
Tome Biosciences came out of stealth mode on 12 December with a haul of over $200 million to develop the company’s gene editing platform. Tome’s first order of business was to snap up Replace Therapeutics to expand its toolkit to...
By Rob Stein, NPR | 04.24.2024
Lisa Pisano was lying in a hospital bed at NYU Langone Health, hooked up to beeping monitors and an array of tubes. Her surgical wounds were still healing, and she looked tired. But the 54-year-old New Jersey woman said she...